Access to Affordable Breast Cancer Care in Eastern Europe

Eniu, Alexandru; Antone, Nicoleta

doi:10.1007/s12609-018-0285-8

Cited by 6 publications

(6 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most substantial inequalities exist in the availability and costs of the medicines, especially with the newer and more expensive ones. 7,25 This potentially could pose a burden on patient self-financing or co-payment.…”

Section: Discussionmentioning

confidence: 99%

“…11 Important limitations and differences among Central and Eastern European (CEE) patients are also observed in terms of availability and costs of new medicines and drug shortages for medicines with well-established use, included in the list of "essential" medicines. 12 The objective of the present study is to evaluate and compare the differences in BC therapy and health-care service practices as well as their availability in ten European countries-Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Republic of North Macedonia, Croatia, Romania, Slovenia, and Republic of Serbia.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

et al. 2020

View full text Add to dashboard Cite

Aim: The aim of this study is to compare the differences in breast cancer therapy, health-care service practices, and their availability in ten European countries—Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Montenegro, Republic of North Macedonia, Croatia, Romania, Slovenia, and Republic of Serbia. Methods: An inquire survey was conducted among oncologists in the participating countries. The questionnaire was of qualitative character and focused on several key areas as screening practices, diagnosing, treatment, and health-care procedures utilization. The results were processed through comparative and percentage analysis. Results: All of the observed countries have national registries for breast cancer, but only in five, a mechanism of controlled action of early detection is implemented. Ninety percent of the countries have implemented in the national guidelines the European Society of Medical Oncology recommendations, while National Comprehensive Cancer Network is considered in only 50%. In all countries, digital mammography is a universal diagnostic method. Pathohistological analysis, including HER2 receptor expression and determination of the level of progesterone and estrogen receptors, is routinely performed in all countries prior to therapy. Some differences are observed in terms of FISH/CISH methods, determination of Ki-67 volume, and prognostic molecular assays. Trastuzumab is used as neo-adjuvant therapy in HER2-positive disease in all countries, while in Bosnia and Herzegovina and Croatia, only pertuzumab is used. Psychological support is integrated into the professional guidelines for treatment and monitoring in Bosnia and Herzegovina, Bulgaria, and Serbia. Conclusions: The international guidelines should be followed strictly, and some improvements in the health policies should be made in order to decrease the differences and inequalities in the availability of the breast cancer (BC) health services in the Central and Eastern European countries.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Fewer medical resources in Central and Eastern European (CEE) countries have led to inequalities in cancer care compared with Western European nations. 30 Of note, CEE countries' survival rates are typically 10%-15% lower than the European average (81.8%; 95% CI, 81.6 to 82.0). 31 The causes of these disparities are undoubtedly multifactorial.…”

Section: Discussionmentioning

confidence: 98%

Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in the European Union and the United Kingdom

Jani

Salcicciol

Rupal

et al. 2021

JCO Global Oncology

View full text Add to dashboard Cite

PURPOSE Breast cancer is the most common cancer in women worldwide, representing 25.4% of the newly diagnosed cases in 2018. The past two decades have seen advancements in screening technologies, guidelines, and newer modalities of treatment. Our study reports and compares trends in breast cancer mortality in the European Union and the United Kingdom. MATERIALS AND METHODS We used the WHO Mortality Database. We extracted breast cancer mortality data from 2001 to 2017 on the basis of the International Classification of Diseases, 10th revision system. Crude mortality rates were dichotomized by sex and reported by year. We computed age-standardized death rates (ASDRs) per 100,000 population using the world standard population. Breast cancer mortality trends were compared using joinpoint regression analysis. RESULTS We analyzed data from 24 EU countries, including the United Kingdom. For women, breast cancer mortality was observed to be downtrending in all countries except Croatia, France, and Poland. For the most recent female data, the highest ASDR for breast cancer was identified in Croatia (19.29 per 100,000), and the lowest ASDR was noted in Spain (12.8 per 100,000). Denmark had the highest change in ASDR and the highest estimated annual percentage change of −3.2%. For men, breast cancer mortality decreased in 18 countries, with the largest relative reduction observed in Denmark with an estimated annual percentage change of −27.5%. For the most recent male data, the highest ASDR for breast cancer was identified in Latvia (0.54 per 100,000). CONCLUSION Breast cancer mortality rates have down trended in most EU countries between 2001 and 2017 for both men and women. Given the observational nature of this study, causality to the observed trends cannot be reliably ascribed. However, possible contributing factors should be considered and subject to further study.

show abstract

“…Some EU countries in Central and Eastern Europe (e.g. Croatia, Romania and Serbia) do not have national cancer plans or cancer registries (Eniu and Antone 2018;Vrdoljak et al 2016). This can be due to limited financial resources, poor infrastructure, or a lack of awareness among policymakers of the importance of investing in cancer care (Eniu and Antone 2018).…”

Section: Politicalmentioning

confidence: 99%

“…Croatia, Romania and Serbia) do not have national cancer plans or cancer registries (Eniu and Antone 2018;Vrdoljak et al 2016). This can be due to limited financial resources, poor infrastructure, or a lack of awareness among policymakers of the importance of investing in cancer care (Eniu and Antone 2018). Even in those countries that do have cancer plans, implementation remains a barrier as it can require major reorganisation of healthcare systems (Cardoso et al 2017), and the EU does not have the mandate to enforce implementation of its health policies.…”

Section: Politicalmentioning

confidence: 99%

Factors affecting access to treatment of early breast cancer: Case studies from Brazil, Canada, Italy, Spain and UK: Implications for future research, policy and practice

Rodriguez-Rincon¹,

Leach²,

d'Angelo³

et al. 2019

View full text Add to dashboard Cite

is a not-for-profit organisation whose mission is to help improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors. All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the sponsor.

show abstract

Access to Affordable Breast Cancer Care in Eastern Europe

Cited by 6 publications

References 33 publications

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries

Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in the European Union and the United Kingdom

Factors affecting access to treatment of early breast cancer: Case studies from Brazil, Canada, Italy, Spain and UK: Implications for future research, policy and practice

Contact Info

Product

Resources

About